Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3:286-95.
Hussain YS, Hookham JC, Allahabadia A, Balasubramanian SP. Epidemiology, management and outcomes of Graves’s' disease-real life data. Endocrine. 2017;56(3):568-578
De Leo S et al. Hyperthyroidism. Lancet. 2016;388:906.
Brix TH, Kyvik KO, Christensen K, and Hegedus L. Evidence for a major role of heredity in Graves’s Disease: A population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab. 2001;86: 930-934
Laurberg P, Pedersen KM, Vestegaard H, and Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low intake area vs. high incidence of Graves’ Disease in the young in a high iodine intake area : Comparative surveys of thyrotoxicosis epidemiology in East Jutland Denmark and Iceland. J. Intern. Med. 1991;229: 415-420
Morshed SA, Latif R, Davies TF. Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology. 2009; 150: 519-29.
Martin A, Schwartz AE, Friedman EW, Davies TF. Successful production of intrathyroidal human T cell hybridomas: evidence for intact helper T cell function in Graves’s’ disease. J Clin Endocrinol Metab. 1989; 69: 1104-8.
Rapoport B, McLachlan SM. Graves’ hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. J Clin Endocrinol Metab. 2014;99:4060-1.
Delpita A, Rachmawati B. Hubungan kadar ferritin dengan TSH dan FT4 akibat transfusi berulang pada penderita thalassemia di RSUP Dr. Kariadi, Semarang, Indonesia. Intisari Sains Medis. 2019;10(2):403-407.
Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362: 726-38.
Cao HJ, Wang HS, Zhang Y, Lin HY, Phipps RP, Smith TJ. Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression: insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy. J Biol Chem. 1998; 273: 29615-25.
Wémeau JL, Klein M, Sadoul JL, Briet C, Vélayoudom-Céphise FL. Graves’s' disease: Introduction, epidemiology, endogenous, and environmental pathogenic factors. Ann. Endocrinol. (Paris). 2018;79(6):599-607
Ross DS et al. American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26:1343.
Biondi B et al. The 2015 European Thyroid Association Guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur Thyroid J. 2015;4:149.
Rago T, Cantisani V, Ianni F, Chiovato L, Garberoglio R, Durante C, et al. Thyroid ultrasonography reporting: consensus of Italian Thyroid Association (AIT), Italian Society of Endocrinology (SIE), Italian Society of Ultrasonography in Medicine and Biology (SIUMB) and Ultrasound Chapter of Italian Society of Medical Radiology (SIRM). J. Endocrinol. Invest. 2018;41(12):1435-1443.
Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism. Eur Thyroid J. 2018;7(4):167-186.
Kotwal A, Stan M. Thyrotropin Receptor Antibodies-An Overview. Ophthalmic Plast Reconstr Surg. 2018;34(4S Suppl 1): S20-S27.
Subekti I, Pramono LA. Current Diagnosis and Management of Graves’ Disease. Acta Med Indones. 2018;50(2):177-182.
Aung ET, Zammitt NN, Dover AR, Strachan MWJ, Seckl JR, Gibb FW. Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosis. Clin. Endocrinol. (Oxf). 2019;90(1):192-199.
Liu ZW, Masterson L, Fish B, Jani P, Chatterjee K. Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy. Cochrane Database Syst Rev.2015;11:CD010576.
Feroci F, Rettori M, Borrelli A, et al. A systematic review and meta-analysis of total thyroidectomy versus bilateral subtotal thyroidectomy for Graves’ disease. Surgery. 2014;155: 529-40.
Andersen SL, Olsen J, Laurberg P. Antithyroid drug side effects in the population and in pregnancy. J Clin Endocrinol Metab. 2016;101:1606-14.
Boboridis KG, Uddin J, Mikropoulos DG, et al. Critical appraisal on orbital decompression for thyroid eye disease: a systematic review and literature search. Adv Ther. 2015;32: 595-611.
Qian J. [The stepwise establishment of standardized treatment for the thyroid eye disease]. Zhonghua Yan Ke Za Zhi. 2017;53(6):404-407.
Wiersinga WM: Advances in treatment of active, moderate-to-severe Graves’ ophthalmopathy. Lancet Diabetes Endocrinol. 2017;5:134.